Identification of low-molecular-weight protein (SCP1) from shark cartilage with anti-angiogenesis activity and sequence similarity to parvalbumin

Journal of Pharmaceutical and Biomedical Analysis

Volumn 46, Issue 3, 2008, Pages 563-567

  Rabbani Chadegani, Azra ^a   Abdossamadi, Sayeh ^a   Bargahi, Afshar ^a   Yousef Masboogh, Marzeih ^a  

^a UNIVERSITY OF TEHRAN   (Iran)

Author keywords

Angiogenesis; Anticancer drugs; Aorta ring assay; Parvalbumin; Shark cartilage

Indexed keywords

ANGIOGENESIS INHIBITOR; PARVALBUMIN; SCP1 PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; CARTILAGE; CIRCULAR DICHROISM; CONTROLLED STUDY; DRUG ISOLATION; GEL FILTRATION; MOLECULAR WEIGHT; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN PURIFICATION; PROTEIN SECONDARY STRUCTURE; RAT; SEQUENCE HOMOLOGY; SHARK; VASCULAR RING;

AMINO ACID SEQUENCE; ANGIOGENESIS INHIBITORS; ANIMALS; CARTILAGE; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; PARVALBUMINS; PROTEIN STRUCTURE, SECONDARY; PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; SHARKS;

EID: 37748999183     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2007.10.029     Document Type: Article

References (27)

1. Folkman J., and Shing Y. Angiogenesis J. Biol. Chem. 267 (1992) 10931-10934
2. Folkman J. Nat. Med. 1 (1995) 27-31
3. Peter C., and Rakesh J.K. Nature 407 (2000) 249-257
4. Brem H., and Folkman J. J. Exp. Med. 141 (1975) 427-439
5. Moses M.A., Sudhalter J., and Langer R. Science 248 (1990) 1408-1410
6. McGuire T.R., Kazakoff P.W., Hoie E.B., and Fienhold M.A. Pharmacotherapy 16 (1996) 237-244
7. Sheu J.R., Fu C.C., Tsai M.L., and Chung W.J. Anticancer Res. 18 (1998) 4435-4441
8. Dupont E., Sarvard P.E., Jourdain C., Juneau C., Thibodeau A., Ross N., Marenus K., Maes D.H., Pelletier G., and Sauder D.N. J. Cutan. Med. Surg. 2 (1998) 146-152
9. Parr C., Gan C.H., Watkins G., and Jiang W.G. Angiogenesis 9 (2006) 73-81
10. Strom S.C., and Michalopoulos G. Methods Enzymol. 82 (1982) 544-555
11. Laemmli U.K. Nature 227 (1970) 680-685
12. Bradford M.M. Anal. Biochem. 72 (1976) 248-254
13. Dieter G., Hons C., and Mailies R. Anal. Biochem. 81 (1976) 492-494
14. Nicosia R.F., and Ottinetti A. Lab. Invest. 63 (1990) 115-122
15. Gonzalez R.P., Leyva A., and Moraes M.O. Biol. Pharm. Bull. 24 (2001) 1097-1101
16. Roquet F., Declercq J.P., Tinant B., Rambaud J., and Parello J. J. Mol. Biol. 223 (1992) 705-720
17. Kuster T., Staudenmann W., Hughes G.J., and Heizmann C.W. Biochemistry 30 (1991) 8812-8816
18. Zuhlke Ch., Schoffl F., Jockusch H., Simon D., and Guenet J.L. Genet. Res. 54 (1989) 37-43
19. Brewer J.M., Wunderlich J.K., and Ragland W. Biochimie 72 (1990) 653-660
20. Berchatold M.W., Heizmann C.W., and Wilson K.J. Eur. J. Biochem. 127 (1982) 381-398
21. Berchatold M.W., Celio M.R., and Heizmann C.W. J. Biol. Chem. 259 (1984) 5189-5196
22. MacManus J.P. Biochem. Biophys. Acta 261 (1980) 296-304
23. Shen X.R., Ji D.M., Jia F.X., Deng X.X., Sun J.H., Hu X.R., and Ren D.M. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 32 (1998) 43-48
24. Bottoms C.A., Schuermann J.P., Agah S., Henzl M.T., and Tanner J.J. Protein Sci. 13 (2004) 1724-1734
25. Gingras D., Renaud A., Mousseau N., Beaulieu E., Kachra Z., and Béliveau R. Anticancer Res. 21 (2001) 145-155
26. Beliveau R., Gingras D., Kruger E.A., Lamy S., Sirois P., Simard B., Sirois M.G., Tranqui L., Baffert F., Beaulieu E., Dimitriadou V., Pepin M.C., Courjal F., Ricard I., Poyet P., Falardeau P., Figg W.D., and Dupont E. Clin. Cancer Res. 8 (2002) 1242-1250
27. Boivin D., Gendron S., Beaulieu E., Gingras D., and Beliveau R. Mol. Cancer Ther. 10 (2002) 795-802